Harrington Discovery Institute and the
American Society for Clinical Investigation seek nominations to
recognize an outstanding achievement by a
physician-scientist
CLEVELAND, July 23,
2024 /PRNewswire/ -- National and international
nominations are being sought for the 2025 Harrington Prize
for Innovation in Medicine, which honors a physician-scientist
who has moved science forward with achievements notable for
innovation, creativity and the potential for clinical
application.
The Harrington Prize, which carries a $20,000 honorarium, is a collaboration between
Harrington Discovery Institute at University Hospitals in
Cleveland, Ohio and the American
Society for Clinical Investigation (ASCI), one of the nation's
oldest and most respected medical honor societies. Harrington
Discovery Institute is a nonprofit institute dedicated to helping
physician-scientists accelerate promising discoveries into
medicines for unmet needs.
Both organizations recognize the challenges associated with
translating academic discoveries into medicines, and they are eager
to highlight those who have navigated the path successfully or
whose work has led to novel treatments.
A committee composed of members of the Harrington Discovery
Institute Scientific Advisory Board and the ASCI Council will
review the nominations and select the awardee. In addition to the
honorarium, the 2025 recipient will deliver the Harrington Prize
Lecture at the 2025 Joint Meeting of the Association of American
Physicians (AAP), the ASCI, and the American Physician Scientists
Association (APSA); will lecture at the 2025 Harrington Discovery
Institute Symposium; and will publish a personal essay in the
Journal of Clinical Investigation.
Submitting a Nomination:
- Nominee must have an MD or MD/PhD (or equivalent).
- Deadline for nominations is September
16, 2024.
- Multiple nominations from an institution are welcomed.
- Teams are accepted for a nomination, but a primary nominee is
required.
- Nomination guidelines can be found at
HarringtonDiscovery.org/Prize.
Harrington Prize Recipients (2014 – 2024):
- 2024: Arlene Sharpe,
MD, PhD, Harvard University, for
her breakthrough discoveries in immune regulation, which have
established foundational principles in immunology and led to new
cancer therapies.
- 2023: Jointly awarded to Jean
Bennett, MD, PhD, and Albert
M. Maguire, MD, both from the Perelman School of
Medicine at the University of
Pennsylvania, for their groundbreaking translational
research to restore sight in inherited genetic disease.
- 2022: Jointly awarded to James E. Crowe, Jr., MD, Vanderbilt University, and Michel C. Nussenzweig, MD, PhD, The Rockefeller University, for their
groundbreaking work in immunology, which has elucidated fundamental
principles of the human immune response and enabled the use of
human antibodies to treat COVID-19.
- 2021: Jointly awarded to Warren J. Leonard, MD, NHLBI, and
John J. O'Shea, MD, NIAMS,
NIH, for their respective contributions to the field of
immunology, from fundamental discovery to therapeutic impact.
- 2020: Stuart H. Orkin,
MD, Harvard University, for
breakthrough discoveries on red blood cells that offer new
treatments for patients with sickle cell disease and
beta-thalassemia, which are among the most common genetic
disorders.
- 2019: Carl H. June,
MD, University of Pennsylvania, for
advancing the clinical application of CAR T therapy for cancer
treatment, and for his sustained contributions to the field of
cellular immunology.
- 2018: Helen H. Hobbs,
MD, UT Southwestern Medical Center, for the discovery of the
link between a gene mutation (PCSK9) and lower levels of LDL, which
has improved the treatment of high cholesterol.
- 2017: Jointly awarded to Daniel J. Drucker, MD, Mount Sinai Hospital,
Canada, Joel F. Habener, MD, Massachusetts General Hospital, and
Jens J. Holst, MD, DMSc,
University of Copenhagen, Denmark,
for their discovery of incretin hormones and for the translation of
these findings into transformative therapies for major metabolic
diseases such as diabetes.
- 2016: Jeffrey M.
Friedman, MD, PhD, The Rockefeller
University, for his discovery of leptin, which controls
feeding behavior and is used to treat related clinical
disorders.
- 2015: Douglas R. Lowy,
MD, The National Cancer Institute, in recognition of his
discoveries that led to the development of the Human Papillomavirus
vaccine to prevent cervical cancer.
- 2014: Harry Dietz, MD,
Johns Hopkins University, for his
contributions to the understanding of the biology and treatment of
Marfan syndrome, a disorder leading to deadly aneurysms in children
and adults.
For questions or more information about the nomination
requirements, visit HarringtonDiscovery.org/Prize or contact
Bronwyn Monroe, Harrington Discovery
Institute Program Director, at
Bronwyn.Monroe@HarringtonDiscovery.org.
View original
content:https://www.prnewswire.com/news-releases/nominations-open-for-12th-annual-international-harrington-prize-for-innovation-in-medicine-302203992.html
SOURCE Harrington Discovery Institute